AI Article Synopsis

  • Sida pilosa, a plant used in Africa for various ailments, was studied for its effectiveness against schistosomiasis mansoni, showing schistosomicidal, antioxidant, and anti-fibrotic properties.
  • Mice infected with S. mansoni treated with aqueous extract or n-butanol fraction of S. pilosa experienced reduced worm burden and liver damage, alongside improvements in various biochemical markers.
  • Both treatments lowered harmful enzyme levels and reversed the effects of infection on certain proteins; however, the n-butanol fraction was less effective than the aqueous extract in some areas.

Article Abstract

Ethnopharmacological Relevance: Sida pilosa Retz (Malvaceae) is a plant used in Africa for the treatment of intestinal helminthiasis, lower abdominal pains and dysmenorrhea.

Aim Of The Study: In order to determine the potential use of S. pilosa in the treatment of schistosomiasis mansoni, we evaluated the schistosomicidal, antioxidant and anti-fibrotic properties of the aqueous extract and the n-butanol fraction of its aerial parts.

Material And Methods: S. pilosa aqueous extract (SpAE) at 100, 200 and 400mg/kg and n-butanol fraction (SpBF) at 50, 100 and 200mg/kg were administered per os to Schistosoma mansoni-infected mice for 4 weeks. Praziquantel (100mg/kg × 5 days) was used as reference drug. After sacrifice, worm burden and egg count, transaminases and proteins levels were evaluated. Malondialdehyde (MDA), lipid hydroperoxydes (LOOH), catalase (CAT), superoxide dismutase (SOD), eosinophil peroxidase (EPO) and myeloperoxidase (MPO) were also measured. The anti-fibrotic effect of the plant was evaluated by the determination of hydroxyproline and γ-interferon (IFN-γ).

Results: The treatment of S. mansoni-infected mice by SpAE or SpBF resulted in a moderate reduction of worm burden and egg load in the liver and intestine. Both SpAE and SpBF significantly reversed the increasing liver proteins, MDA, LOOH and CAT levels induced by the infection. Moreover, SOD activity was improved by SpAE and SpBF. Schistosomiasis mansoni considerably increased the EPO (p<0.001) and MPO activities (p<0.001). SpAE treatment significantly reduced EPO and MPO activities at all doses. SpBF failed to reduce the increasing MPO and decreased EPO only at the highest dose. S. mansoni-infection induced an increase in hydroxyproline content (p<0.001) and a decrease in IFN-γ level (p<0.001). Both SpAE and SpBF significantly reduced hepatic hydroxyproline content, while only SpAE (p<0.05) improved IFN-γ level.

Conclusion: These results suggest that the liver pathology in schistosomiasis mansoni is improved by S. pilosa aqueous extract, which disclosed a moderate schistosomicidal, but strong antioxidant and anti-fibrotic activities. The n-butanol fraction was however less active than the aqueous extract.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2016.01.017DOI Listing

Publication Analysis

Top Keywords

aqueous extract
12
n-butanol fraction
12
mansoni-infected mice
12
spae spbf
12
extract n-butanol
8
sida pilosa
8
pilosa retz
8
schistosoma mansoni-infected
8
schistosomiasis mansoni
8
worm burden
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!